William Blair & Company
AGN

William Blair & Company’s Allergan Inc AGN Stock Holding History

William Blair & Company’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-153,705
Closed -$32.7M – 2268
2014
Q4 		$32.7M Sell
153,705
-3,573
-2% -$711K 0.05% 440
2014
Q3 		$28M Sell
157,278
-23,059
-13% -$3.83M 0.05% 452
2014
Q2 		$30.5M Sell
180,337
-1,350,833
-88% -$210M 0.05% 436
2014
Q1 		$190M Sell
1,531,170
-203,004
-12% -$24.7M 0.31% 79
2013
Q4 		$193M Buy
1,734,174
+80,033
+5% +$7.64M 0.32% 77
2013
Q3 		$150M Buy
1,654,141
+66,665
+4% +$5.98M 0.27% 104
2013
Q2 		$134M Buy
+1,587,476
New +$165M 0.26% 98

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

William Blair & Company's AGN Position: Q1 2015 in Review

William Blair & Company sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 153,705 shares — an estimated $32.7M sold.

William Blair & Company first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $193M in Q4 2013. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • William Blair & Company reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • William Blair & Company sold 153,705 Allergan Inc shares in Q1 2015, an estimated $32.7M.
  • William Blair & Company first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • William Blair & Company's Allergan Inc position peaked at $193M in Q4 2013.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on William Blair & Company's 13F filing for Q1 2015, filed 11 May 2015.